TD Asset Management Inc Decreases Position in Encompass Health Corporation $EHC

TD Asset Management Inc decreased its stake in Encompass Health Corporation (NYSE:EHC) by 10.0% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 923,183 shares of the company’s stock after selling 102,669 shares during the quarter. TD Asset Management Inc owned about 0.92% of Encompass Health worth $117,263,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Citizens National Bank Trust Department purchased a new position in Encompass Health during the third quarter worth $26,000. First Horizon Corp purchased a new stake in shares of Encompass Health in the third quarter valued at $34,000. Westside Investment Management Inc. lifted its holdings in shares of Encompass Health by 56.7% in the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after acquiring an additional 101 shares during the last quarter. Assetmark Inc. boosted its stake in shares of Encompass Health by 88.1% during the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after purchasing an additional 140 shares during the period. Finally, Root Financial Partners LLC bought a new position in Encompass Health during the 3rd quarter valued at about $39,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Barclays boosted their target price on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research report on Friday, February 6th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Finally, Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $143.29.

Insider Buying and Selling

In other Encompass Health news, CEO Mark J. Tarr sold 150,000 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the transaction, the chief executive officer owned 377,070 shares of the company’s stock, valued at approximately $42,096,094.80. This trade represents a 28.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 2.00% of the company’s stock.

Encompass Health Stock Up 1.2%

Shares of NYSE EHC opened at $106.12 on Thursday. Encompass Health Corporation has a 52-week low of $92.53 and a 52-week high of $127.99. The firm has a market capitalization of $10.68 billion, a price-to-earnings ratio of 19.15, a PEG ratio of 1.99 and a beta of 0.73. The stock has a 50 day moving average price of $103.84 and a 200 day moving average price of $114.23. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.08.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The business had revenue of $3.09 billion during the quarter, compared to analyst estimates of $1.54 billion. During the same period in the previous year, the company posted $1.17 EPS. Encompass Health’s revenue was up 9.9% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Sell-side analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be paid a $0.19 dividend. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s dividend payout ratio is 13.72%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.